How to Use drugmaker in a Sentence

drugmaker

noun

• The state’s lawyers called for the drugmaker’s suit to be dismissed.
  — Los Angeles Times, 14 July 2022
• The product’s list price was $2,100 per dose, the drugmaker said then.
  — Alexander Ruoff, Fortune, 31 Aug. 2022
• One root of the problem is the very high prices set by drugmakers.
  — Kff Health News, The Mercury News, 23 Oct. 2023
• The increase was mainly driven by sales of the over-the-counter version, the drugmaker said.
  — Sara G. Miller, NBC News, 11 Mar. 2024
• The drugmaker was aiming to match the rate of Aubagio, an oral drug for the disease owned by Sanofi.
  — David Sachs, WSJ, 6 Dec. 2023
• The pill in the new study — made by the Spanish drugmaker Ferrer — was approved for use in Europe in 2014.
  — Erika Edwards, NBC News, 26 Aug. 2022
• The drugmaker’s request hints at the extent of the challenge that new strains of the virus could pose to treatments and vaccines.
  — Peter Loftus, WSJ, 16 Apr. 2021
• The bottom line: The balance of power is shifting back to the brand-name GLP-1 drugmakers.
  — Nathan Bomey, Axios, 3 Oct. 2024
• The drugmaker cancelled the agreement the next year and moved forward with the development of the drug.
  — Brian Maffly, The Salt Lake Tribune, 16 May 2021
• The two have raked in tens of billions of dollars in revenue for the Danish drugmaker so far.
  — Sydney Lake, Fortune Asia, 19 June 2024
• The drugmaker is looking for new products to make up for the huge gap left by the fading pandemic.
  — Madison Muller, Fortune, 1 Dec. 2023
• Yet demand is so strong the drugmaker, Novo Nordisk, can’t keep up.
  — Claudia Wallis, Scientific American, 26 Apr. 2022
• The specialized tool will help researchers track the virus’ spread and keep tabs on its evolution, the drugmaker said.
  — Robert Hart, Forbes, 26 Jan. 2023
• On the short list is Civica Rx, a nonprofit drugmaker based in Utah.
  — Los Angeles Times, 6 June 2022
• Last year, the agency placed a hold on a study by drugmaker Cadence Health, which has also been working on an over-the-counter pill.
  — Matthew Perrone, Chicago Tribune, 11 July 2022
• The drugmaker charges your health plan its normal portion of the drug cost, but the patient doesn't pay their normal copay share.
  — Katie Wedell, USA TODAY, 1 Nov. 2022
• The drugmaker also raised its full-year 2023 sales forecast.
  — WSJ, 1 Aug. 2023
• But the drugmaker says 50 micrograms ought to be enough for a booster for healthy people.
  — Matthew Perrone, Fortune, 12 Oct. 2021
• The doses had been bottled at a factory near Rome that is part of the drugmaker’s supply chain.
  — Jenny Strasburg, WSJ, 12 Mar. 2021
• Emergent had contracted to make the covid vaccine for the drugmaker.
  — Chris Isidore, CNN, 26 Apr. 2021
• That’s the initial Rompe Pecho recall that the drugmaker expanded a few days ago to include the new lots above.
  — Chris Smith, BGR, 16 Dec. 2021
• There, the drugmaker will add a new label with warnings about the risk of clots and steps for recognizing and treating them.
  — Eve Sneider, Wired, 23 Apr. 2021
• The drugmaker and its partner cut the typical time to develop a vaccine from more than 10 years to less than one.
  — Wsj Staff, WSJ, 24 Dec. 2020
• The Danish drugmaker is using the results to build its case that cost-conscious insurers should pay for the medicine, which has a list price of about $1,350 per month in the US.
  — Naomi Kresge, Fortune, 6 Apr. 2024
• The drugmaker will receive nearly $2 billion for that deal as well.
  — NOLA.com, 23 Dec. 2020
• While the drugmaker is working to resolve the issue, a quick fix is unlikely.
  — Elizabeth Robinson, NBC News, 18 Apr. 2024
• Hundreds of billions dollars have been spent by drugmakers around the world to try and treat Alzheimer’s, but there’s currently no cure for the disease.
  — Time, 4 July 2023
• Part of this is due to side effects—mostly muscle aches—that were not made clear by drugmakers when statins were first approved.
  — Kaitlin Sullivan, Health, 14 Dec. 2023
• Zoom in: The program works by awarding a drugmaker a voucher once it's received approval for a rare disease therapeutic.
  — Victoria Knight, Axios, 26 Nov. 2024
• One of the few stocks to hurt the index nearly as much was Eli Lilly, which sank 6.3% amid concerns about two of the drugmaker’s blockbuster products: diabetes treatment Mounjaro and weight loss counterpart Zepbound.
  — Stan Choe, Los Angeles Times, 30 Oct. 2024

Last Updated: 9 Jan 2025